A major recall is currently impacting thousands of households as federal officials pull nearly 90,000 bottles of a common pediatric pain reliever from the market. The U.S. Food and Drug Administration (FDA) issued the alert for liquid children’s ibuprofen after parents reported finding “black particles” and “gel-like masses” inside the medication. The contamination concerns have led to a nationwide effort to remove the affected lots from store shelves.
The recall specifically involves 4-fluid-ounce bottles of Children’s Ibuprofen Oral Suspension (100 mg per 5 mL). These products were manufactured in India by Strides Pharma Inc. for Taro Pharmaceuticals U.S.A. and distributed to retailers across the country. While the medication is a staple in many family medicine cabinets for treating fever and minor aches, the presence of foreign material has made these specific batches unsafe for use.
Caregivers are urged to check their current supply for the following identifying details:
• Lot Numbers: 7261973A or 7261974A
• Expiration Date: January 31, 2027
• NDC Number: 51672-5321-8
The FDA has officially designated this as a Class II recall. This classification means that while the risk of permanent or life-threatening injury is considered low, exposure to the contaminated liquid could lead to “temporary or medically reversible” health issues.
As of now, the recall is being managed primarily at the retail level, but health experts insist that parents should stop using any matching bottles immediately.
If you discover that you have an affected bottle, it is recommended to dispose of it or return it to the place of purchase. Parents whose children may have already ingested the medication should monitor for unusual symptoms and consult a pediatrician as a precaution.
For general safety, experts at What to Expect remind parents to always speak with a doctor before administering any new medication to “a child under 2 years old.”
